Period:
Draw Mode:
Low
0.065
High
0.26
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Resverlogix Corp | RVX | Toronto | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.075 | 14:23:31 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.075 | 0.075 | 0.075 | 0.075 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 5 | 211,000 | - | 0.065 - 0.26 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:23:29 | 6,000 | $ 0.075 | CAD |
Resverlogix Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 20.08M | 267.80M | - | 109k | -3.61M | -0.01 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Resverlogix News
| Date | Time | Source | News Article |
|---|---|---|---|
| 9/30/2022 | 05:00 | GlobeNewswire Inc. | InvestmentPitch Media Video Discusses Resverlogix and its.. |
| 9/28/2022 | 06:12 | GlobeNewswire Inc. | Resverlogix Confirms Focus on Treatment of Post COVID-19.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RVX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.08 | 0.085 | 0.075 | 0.0799697 | 82,993 | -0.005 | -6.25% |
| 1 Month | 0.085 | 0.085 | 0.065 | 0.0772283 | 95,954 | -0.01 | -11.76% |
| 3 Months | 0.08 | 0.115 | 0.065 | 0.092249 | 117,412 | -0.005 | -6.25% |
| 6 Months | 0.16 | 0.26 | 0.065 | 0.1280972 | 128,096 | -0.085 | -53.13% |
| 1 Year | 0.20 | 0.26 | 0.065 | 0.1397764 | 90,651 | -0.125 | -62.5% |
| 3 Years | 1.26 | 1.52 | 0.065 | 0.4406103 | 67,271 | -1.19 | -94.05% |
| 5 Years | 3.18 | 4.94 | 0.065 | 1.18 | 79,554 | -3.11 | -97.64% |
Resverlogix Description
| Resverlogix Corp clinical-stage biotechnology company. |